Effect of an Artificial Pancreas System on Glycemic Control in Patients With Type 1 Diabetes
Status: Recruiting
Intervention Type: Device
Study Type: Observational
SUMMARY
The goal of this study is compare the effect of hybrid closed loop system (HCL) for automatic insulin dosing treatment on the glycemic control of type 1 diabetes (T1D) in patient with different initial glycated hemoglobin.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• patients with T1D
• Type 1 diabetes for \> 1 years
• ≥ 18 years old
• CSII (without HCL) or MDI
Contact Information
Primary
Lucie Radovnická
radovnickal@gmail.com
+420777624793
Backup
Jiri Lastuvka
jiri.lastuvka@kzcr.eu
1420477114202
Time Frame
Start Date: 2022-12-01
Estimated Completion Date: 2024-05-01
Participants
Target number of participants: 120
Treatments
group 1 with Control IQ system
Tandem t:slim X2 with hybrid closed loop system Control IQ, glucose sensor: Dexcom G6
Group 2 with SmartGuard system
MiniMed 780G, with hybrid closed loop system SmartGuard, sensor Guardien 4
Related Therapeutic Areas
Sponsors
Leads: Masaryk Hospital Usti nad Labem